Gilead's earnings jump on strong drug sales
October 20, 2009 at 16:48 PM EDT
Gilead Sciences reported higher third-quarter earnings late Tuesday, its performance stoked by strong sales of its HIV drugs and dramatically increased royalty revenue from its influenza medication Tamiflu.
